Pharma and Biotech Daily: FDA Revives Drug for Autism, Tylenol Pregnancy Warning, and More!
Update: 2025-09-24
Description
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA has revived a long-dormant drug from GlaxoSmithKline as a potential treatment for autism. The agency also mentioned the potential link between the use of Tylenol and other acetaminophen products during pregnancy and neurological and developmental defects in children. In other news, Scholar Rock's spinal muscular atrophy drug faced manufacturing site issues, while Lexicon's type 1 diabetes drug experienced regulatory delays. Merck's ProQuad vaccine history was examined amid changing vaccine guidelines. Kennedy's criticism of childhood vaccines was also discussed. Biotility offers industry-recognized credentials for bioscience professionals, while a variety of biopharma news and upcoming events were highlighted.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
